AT1 3.85% 2.5¢ atomo diagnostics limited

Media Update, page-1804

  1. 162 Posts.
    lightbulb Created with Sketch. 32
    I agree with this. However, and I mean this respectfully, one needs to take ownership of one's investment decisions and emotional responses. A handful of like minded people does not make a point of view correct - it sometimes just serves to reinforce biases.

    If I pause and look at the situation, I see: major stakeholders still onboard (even accumulating in late 2021); pending FebriDX and Antigen test approvals; recruitment of US based senior staff with US experience; consulting assistance from Bondi Partners (who garnered Ellume US business); a growing HIV business (+135 countries); a business with no debt, an innovative product, and a sound, experienced, and globally focused board.

    I will give it time. Things may or may not work - who knows. Though, I am hopeful they will.

    In the meantime, I am chuffed at the fact that I partly own (however small my part is) a company that is helping people manage their health around the world. Isn't this what investing is?


 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.